크레아티닌 측정법 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 검사 유형별, 제품별, 샘플별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Creatinine Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Product, By Sample, By End User, By Region and Competition, 2020-2030F
상품코드:1797044
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 크레아티닌 측정법 시장은 2024년에 6억 4,029만 달러로 평가되며, 예측 기간 중 CAGR은 7.48%로, 2030년에는 9억 8,715만 달러에 달할 것으로 예측됩니다.
크레아티닌 측정 검사는 인체의 신장 기능을 평가하기 위해 실시합니다. 크레아티닌은 근육에서 에너지 생산 후 체내에 남아있는 화학 화합물입니다. 혈액이나 소변 샘플의 크레아티닌 농도를 측정하여 크레아티닌을 걸러내는 신장의 상태를 알 수 있습니다. 성인의 경우 크레아티닌의 정상 수치는 혈액 1데시리터당 0.5-1.2밀리그램입니다. 크레아티닌 수치가 높을수록 신장이 건강하지 않다는 것을 나타냅니다. 특히 개발도상국에서는 열악한 생활환경으로 인해 전 세계에서 신장질환의 유병률이 증가하고 있으며, 크레아티닌 측정 검사에 대한 수요가 증가하고 있습니다. 또한 검사 키트 및 시약의 비용 효율성과 접근성 또한 시장 성장에 기여하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
6억 4,029만 달러
시장 규모 : 2030년
9억 8,715만 달러
CAGR : 2025-2030년
7.48%
급성장 부문
시약
최대 시장
북미
시장 성장 촉진요인
신장 관련 건강 문제 증가
주요 시장 이슈
크레아티닌 검사법에 대한 인식 부족
주요 시장 동향
POC(Point-Of-Care) 검사
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 크레아티닌 측정법 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
검사 유형별(Jaffe Kinetic Method, 효소법)
제품별(시약, 키트)
샘플별(혈액/혈청, 뇨)
최종사용자별(병원, 진단 연구소)
지역별
기업별(2024년)
시장 맵
제6장 북미의 크레아티닌 측정법 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 크레아티닌 측정법 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 크레아티닌 측정법 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 크레아티닌 측정법 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 크레아티닌 측정법 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
제13장 세계의 크레아티닌 측정법 시장 : SWOT 분석
제14장 경쟁 구도
Abbott Laboratories
Thermo Fisher Scientific
Merck KGaA
Quidel Corporation
Cell Biolabs, Inc.
Genway Biotech
Randox Laboratories Ltd.
ACON Laboratories
Nova Biomedical
Sysmex India Pvt. Ltd.
제15장 전략적 제안
제16장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
Global Creatinine Assay Market was valued at USD 640.29 Million in 2024 and is expected to reach USD 987.15 Million by 2030 with a CAGR of 7.48% during the forecast period. The creatinine measurement test is performed to assess renal function in the human body. Creatinine is a chemical compound that remains in the body after energy production in the muscles. By measuring creatinine levels in blood and urine samples, the status of the kidneys can be determined as they filter out creatinine. In adults, a normal creatinine measurement ranges from 0.5 to 1.2 milligrams per deciliter of blood. Higher levels of creatinine indicate unhealthy kidney conditions. The increasing prevalence of kidney diseases worldwide, particularly in developing countries, due to unfavorable living conditions, has led to a growing demand for creatinine measurement tests. Additionally, the cost-effectiveness and easy availability of test kits and reagents are contributing to market growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 640.29 Million
Market Size 2030
USD 987.15 Million
CAGR 2025-2030
7.48%
Fastest Growing Segment
Reagents
Largest Market
North America
Key Market Drivers
Growing Kidney Related Health Problems
Kidney disorder, particularly chronic kidney disease (CKD), is a prominent contributor to global mortality rates. Timely diagnosis and appropriate treatment are crucial in preventing complications. Creatinine testing methods are employed to assess renal functionality. Key market players are prioritizing the production of high-quality products to meet the growing demand. Additionally, the continual increase in research activities in this field is propelling the global market's expansion. With an increasing number of people being diagnosed with kidney-related diseases, there is a higher demand for creatinine testing to assess kidney function and monitor disease progression. Patients with kidney diseases require regular monitoring of their kidney function, including creatinine levels. This ongoing monitoring drives the need for frequent creatinine testing. Creatinine assays are routinely performed in hospitals, clinics, and other healthcare facilities to assess kidney function in patients admitted with kidney-related issues or undergoing treatments that may impact kidney function. The need for rapid results and immediate clinical decision-making in critical care settings has driven the adoption of point-of-care creatinine testing, allowing for timely patient management. In the pharmaceutical industry, creatinine assays are utilized in pre-clinical and clinical research to assess the impact of new drugs on kidney function and potential nephrotoxicity. As awareness about kidney health increases, more people are undergoing routine health check-ups that include creatinine testing to identify early signs of kidney dysfunction which is boosting the global creatinine assay market.
Key Market Challenges
Lack Of Awareness About Creatinine Testing Methods
Many patients may not be aware of the importance of creatinine testing in assessing kidney function and may not understand its significance in their overall health. Different healthcare settings may use various methods for creatinine testing, leading to confusion among patients and providers about the accuracy and reliability of results. In some cases, healthcare providers may prioritize other health parameters over creatinine testing, potentially overlooking early signs of kidney dysfunction. Public health initiatives and awareness campaigns may not adequately address the importance of kidney health and creatinine testing in promoting overall well-being.
Key Market Trends
Point-of-Care Testing
POCT can be performed at the patient's bedside, in outpatient clinics, or even in remote or resource-limited areas. It eliminates the need for patients to visit a centralized laboratory for creatinine testing, enhancing accessibility to diagnostic services. For patients with chronic kidney disease (CKD) or those undergoing treatments that may impact kidney function, POCT allows for frequent and easy monitoring of creatinine levels, enabling timely adjustments to treatment plans. In telemedicine or remote healthcare settings, POCT of creatinine allows for remote monitoring of kidney function, promoting continuity of care and personalized treatment plans. POCT can lead to cost savings by reducing the need for multiple visits or sample transportation to centralized laboratories.
Key Market Players
Abbott Laboratories
Thermo Fisher Scientific
Merck KGaA
Quidel Corporation
Cell Biolabs, Inc.
Genway Biotech
Randox Laboratories Ltd.
ACON Laboratories
Nova Biomedical
Sysmex India Pvt. Ltd.
Report Scope:
In this report, the Global Creatinine Assay Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Creatinine Assay Market, By Test Type:
Jaffe Kinetic Method
Enzymatic Method
Creatinine Assay Market, By Product:
Reagents
Kits
Creatinine Assay Market, By Sample:
Blood/Serum
Urine
Creatinine Assay Market, By End User:
Hospitals
Diagnostic Laboratories
Creatinine Assay Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Creatinine Assay Market.
Available Customizations:
Global Creatinine Assay market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Creatinine Assay Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Jaffe Kinetic Method, Enzymatic Method)
5.2.2. By Product (Reagents, Kits)
5.2.3. By Sample (Blood/Serum, Urine)
5.2.4. By End User (Hospitals, Diagnostic Laboratories)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Creatinine Assay Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By Product
6.2.3. By Sample
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Creatinine Assay Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By Product
6.3.1.2.3. By Sample
6.3.1.2.4. By End User
6.3.2. Canada Creatinine Assay Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By Product
6.3.2.2.3. By Sample
6.3.2.2.4. By End User
6.3.3. Mexico Creatinine Assay Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By Product
6.3.3.2.3. By Sample
6.3.3.2.4. By End User
7. Europe Creatinine Assay Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Product
7.2.3. By Sample
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Creatinine Assay Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By Product
7.3.1.2.3. By Sample
7.3.1.2.4. By End User
7.3.2. United Kingdom Creatinine Assay Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By Product
7.3.2.2.3. By Sample
7.3.2.2.4. By End User
7.3.3. Italy Creatinine Assay Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By Product
7.3.3.2.3. By Sample
7.3.3.2.4. By End User
7.3.4. France Creatinine Assay Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By Product
7.3.4.2.3. By Sample
7.3.4.2.4. By End User
7.3.5. Spain Creatinine Assay Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By Product
7.3.5.2.3. By Sample
7.3.5.2.4. By End User
8. Asia-Pacific Creatinine Assay Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Product
8.2.3. By Sample
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Creatinine Assay Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By Product
8.3.1.2.3. By Sample
8.3.1.2.4. By End User
8.3.2. India Creatinine Assay Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By Product
8.3.2.2.3. By Sample
8.3.2.2.4. By End User
8.3.3. Japan Creatinine Assay Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By Product
8.3.3.2.3. By Sample
8.3.3.2.4. By End User
8.3.4. South Korea Creatinine Assay Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By Product
8.3.4.2.3. By Sample
8.3.4.2.4. By End User
8.3.5. Australia Creatinine Assay Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By Product
8.3.5.2.3. By Sample
8.3.5.2.4. By End User
9. South America Creatinine Assay Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By Product
9.2.3. By Sample
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Creatinine Assay Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By Product
9.3.1.2.3. By Sample
9.3.1.2.4. By End User
9.3.2. Argentina Creatinine Assay Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By Product
9.3.2.2.3. By Sample
9.3.2.2.4. By End User
9.3.3. Colombia Creatinine Assay Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By Product
9.3.3.2.3. By Sample
9.3.3.2.4. By End User
10. Middle East and Africa Creatinine Assay Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type
10.2.2. By Product
10.2.3. By Sample
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Creatinine Assay Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By Product
10.3.1.2.3. By Sample
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Creatinine Assay Market Outlook
